论文信息 - Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors - 字舞流文

Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors

P. LoRusso | G. Schwartz | J. Bendell | R. Kudchadkar | M. Gordon | G. Edelman | M. Dickson | D. Clary | S. Johnston